Cigna Corp. fell $1.94 or 1.6 percent, to $120.57. Humana Inc. fell $2.38 or 1.5 percent, to $159.73. UnitedHealth Group fell $1.91 or 1.7 percent, to $112.88.» Read More
JPMorgan Chase, the Bill & Melinda Gates Foundation and others have launched an investment fund focused on late-stage healthcare technology trials.
Because the surgeries allow people to continue working and earning, they more than offset their average cost, according to a new study.
Patients whose doctors sell their practices to hospitals could see prices rise, at least in the short term, experts say.
A study of hospitals found a big disparity between official charges for hip- and knee-replacement surgeries, and that high-volume facilities are often the best choice.
Insurance stocks have a had a solid run, but the delay of employer mandate in the health-care reform law shouldn't derail that for now.
The delay of one of the key provisions of the Affordable Care Act has raised many questions. CNBC invited different analysts and experts to discuss the implications of the postponement.
Obamacare is supposed to be inclusive but there are loopholes, and some small-business owners are at risk for winding up falling into the gaps in health-care coverage.
Hedge Fund Glenview Capital wants a shake-up of the board of Health Management Associates, saying the health-care company has underperformed its competitors.
Months before Americans buy coverage under Obamacare, it's becoming clear that choices for millions of people will vary depending on where they live. The NYT reports.
Obamacare's implementation may look like a "train wreck," but Universal Health Services CEO Alan Miller says his $7 billion hospital company is well-positioned for the changes.
Transplant experts will meet to decide whether and how to change the rules for children, after the parents of two youngsters successfully sued to get restrictions temporarily lifted.
A rift between labor unions and the White House over coverage through Obamacare might be putting smiles on opponents of the health care law.
Adrian Bignell, fund manager at Invesco, says that Europe has never been cheaper against the U.S. and that headwinds are starting to abate, and explains his exposure to France.
Bristol-Myers Squibb and Merck stocks climbed higher Monday as analysts said billions stood to be made from treatment breakthroughs.
Peter Wilmshurst, Portfolio Manager, Templeton Global Equity Group at Franklin Templeton Investments tells CNBC's Cash Flow why he likes pharmaceutical stocks at the moment.
Under Obamacare, employers offering more generous benefits to highly paid workers could face fines of $100 a day for every worker who doesn't get the perks, up to $500,000.
Keith Smith, Co-founder, Managing Partner at the Surgery Center of Oklahoma says that all funds are channeled to patient care, helping his team deliver quality healthcare and low costs.
The rise of "superbugs," and pressure from the government and insurers, is driving hospitals to try all sorts of new approaches to stop their spread.
In addition to superbugs' deadly human toll, associated health costs run into the billions. Some warn that we may never win our war against them as research tapers off.
A new study indicates that Obama's health care overhaul will result in a 32 percent claims cost increase which could translate into higher premiums for Americans.